ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD

ClinicalTrials.gov ID: NCT05624268

Public ClinicalTrials.gov record NCT05624268. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 12:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant Depression

Study identification

NCT ID
NCT05624268
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
COMPASS Pathways
Industry
Enrollment
255 participants

Conditions and interventions

Interventions

  • Psilocybin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 18, 2023
Primary completion
May 27, 2025
Completion
Mar 31, 2026
Last update posted
Dec 17, 2025

2023 – 2026

United States locations

U.S. sites
40
U.S. states
19
U.S. cities
33
Facility City State ZIP Site status
University of Arizona College of Medicine - Tuscon Tucson Arizona 85724
ProScience Research Group Culver City California 90230
Collaborative Neuroscience Network, LLC Garden Grove California 92845
Kadima Neuropsychiatry Institute La Jolla California 92037
University California San Diego La Jolla California 92037
California Center for Psychedelic Therapy Los Angeles California 90004
CalNeuro Research Group, Inc Los Angeles California 90025
Clarity Clinical Research, LLC Los Angeles California 90064
ATP Clinical Research, Inc. Orange California 92868
Artemis Institute for Clinical Research San Diego California 92103
Lumos Clinical Research Center San Jose California 95124
Stanford University Stanford California 94305
ASCLEPES Research Centers Thousand Oaks California 93012
Comprehensive Psychiatric Care Norwich Connecticut 06360
Clinical Neurosciecne Solutions, Inc. dba CNS Healthcare Orlando Florida 32801
APG Research, LLC Orlando Florida 32803
DMI Health Care Group, Inc Tampa Florida 33782
Meridien Research/Accel Research Tampa Florida 33803
Psych Atlanta Atlanta Georgia 30060
Emory University Atlanta Georgia 30329-2209
Uptown Research Institute, LLC Chicago Illinois 60640
Sheppard Pratt Health System Baltimore Maryland 21044
CBH Health, LLC Gaithersburg Maryland 20877
Pharmasite Research, Inc Pikesville Maryland 21208
University of Massachusetts Medical School North Worcester Massachusetts 01655
University of Minnesota Minneapolis Minnesota 55416
University of Missouri Columbia Missouri 65212
Midwest Research Group Saint Charles Missouri 63304
Washington University School of Medicine St Louis Missouri 63110
Alivation Research, LLC. Lincoln Nebraska 68526
Bio Behavioral Health Toms River New Jersey 08755
New York State Psychiatric Institute New York New York 10032
The Medical Research Network, LLC New York New York 10128
Insight Clinical Trials, LLC Beachwood Ohio 44122
Neuro-Behaviroral Clinical Research, Inc. North Canton Ohio 44720
Rivus Wellness & Research Institute Oklahoma City Oklahoma 73112
Global Medical Institutes, LLC, Scranton Medical Institute Moosic Pennsylvania 18507
UT Health Science Center at Houston (UTHSC-H) Houston Texas 77030
Cedar Clinical Research Draper Utah 84020
Core Clinical Research Everett Washington 98201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05624268, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 17, 2025 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05624268 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →